Assessment of Phosphatidyl Serine-Specific Phospholipase A1, and CH50 in Sera of Systemic Lupus Erythematosus Patients and Its Correlation with Disease Activity, and Severity - Egyptian Knowledge Bank - troweb

320229

Assessment of Phosphatidyl Serine-Specific Phospholipase A1, and CH50 in Sera of Systemic Lupus Erythematosus Patients and Its Correlation with Disease Activity, and Severity

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Study of Dyslipidemia in Patients with Systemic Lupus Erythematosus and its Correlation to Disease Activity

Article

Assessment of Serum Syndecan-1 and its Relation to Renal Involvement in Patients with Systemic Lupus Erythematosus

Article

Serum Adiponectin Level in Patients with Systemic Lupus Erythematosus and its Correlation with Disease Activity

Article

Correlation of Serum Neopterin level with Complement C3, C4 in assessment of Systemic Lupus Erythematosus Activity

Article

Hypophosphatemia and Hyponatremia in Systemic Lupus Erythematosus Patients and Its Relation to Clinical Characteristic and Disease Activity

Article

Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios and Their Relation with Disease Activity in Systemic Lupus Erythematosus Patients

Article

Serum Neopterin Level in Systemic Lupus Erythematosus: Relation toDisease Activity, Organ Affection and Different Therapy Regimens

Article

Serum levels of soluble CD95 in patients with systemic lupus erythematosus

Article

Neurological Study of Patients with Systemic Lupus Erythematosus

Article

Serum lipoxin A4 as a biomarker for systemic lupus erythematosus